1. Home
  2. SD vs DNA Comparison

SD vs DNA Comparison

Compare SD & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SandRidge Energy Inc.

SD

SandRidge Energy Inc.

HOLD

Current Price

$16.81

Market Cap

589.9M

Sector

Energy

ML Signal

HOLD

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

BUY

Current Price

$10.10

Market Cap

607.1M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
SD
DNA
Founded
2006
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
589.9M
607.1M
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
SD
DNA
Price
$16.81
$10.10
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
$10.50
AVG Volume (30 Days)
305.7K
968.0K
Earning Date
03-09-2026
02-24-2026
Dividend Yield
2.98%
N/A
EPS Growth
40.92
N/A
EPS
1.79
N/A
Revenue
$155,930,000.00
$180,606,000.00
Revenue This Year
$31.95
N/A
Revenue Next Year
$16.82
$3.07
P/E Ratio
$9.01
N/A
Revenue Growth
29.68
N/A
52 Week Low
$8.81
$5.00
52 Week High
$16.61
$17.58

Technical Indicators

Market Signals
Indicator
SD
DNA
Relative Strength Index (RSI) 67.05 46.87
Support Level $15.69 $7.73
Resistance Level $16.61 $9.05
Average True Range (ATR) 0.51 0.66
MACD 0.09 -0.14
Stochastic Oscillator 83.17 34.72

Price Performance

Historical Comparison
SD
DNA

About SD SandRidge Energy Inc.

SandRidge Energy Inc is a United States-based oil and natural gas company. It is engaged in the exploration, development, and production of crude oil, natural gas, and Natural gas liquids. Business activities of the group include Exploration and Production, Drilling and Oil Field Services, and Midstream Gas Services. Its primary areas of operation are the Mid-Continent in Oklahoma and Kansas.

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Share on Social Networks: